Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients

CHENG Guo-wei; SUN Li; CHEN Ping; HE Xiang-ling; SU Dan; XI Heng-zhi; ZANG Ding-qi

doi:10.16689/j.cnki.cn11-9349/r.2019.03.012

PDF(548 KB)

Electronic Journal of Metabolism and Nutrition of Cancer ›› 2019, Vol. 6 ›› Issue (3) : 332-336. DOI: 10.16689/j.cnki.cn11-9349/r.2019.03.012

Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients

CHENG Guo-wei， SUN Li， CHEN Ping， HE Xiang-ling， SU Dan， XI Heng-zhi， ZANG Ding-qi

Author information +

History +

Abstract

Objective To evaluate the effects of different nutritional support methods on short-term efficacy and adverse reactions of patients with advanced esophageal cancer during radiotherapy. Methods According to nutritional intervention， patients were divided into the experimental group and the control group. The experimental group （n=67） was given nasojejunal nutrition tube feeding， while the control group （n=67） was given dietary guidance， oral nutrition or parenteral nutrition. Short-term efficacy， incidence of adverse reactions and treatment completion were compared between the two groups， and nutrition-related adverse events were analyzed. Results The two sets of data were comparable and balanced. The effective rate of radiotherapy in the experimental group was higher than that in the control group， but there was no statistical difference （P>0.05）. The incidence of gastrointestinal bleeding grade 3 or above radioactive esophagitis in the experimental group was significantly lower than that in the control group （P<0.05）， but there was no difference in the incidence of grade 3 or above bone marrow suppression and grade 2 or above radioactive pneumonia （P>0.05）. The treatment completion rate of the experimental group was higher than that of the control group （P<0.05）. Weight loss at the end of radiotherapy and 1month after radiotherapy were significantly lower in the experimental group than those in the control group （P<0.05）. All patients in the experimental group were removed from the jejunal nutrition tube within 1month after the end of radiotherapy. 5.97% of the patients developed esophageal reflux， aspiration and aspiration pneumonia， without affecting the original treatment plan. Conclusion When patients with advanced esophageal cancer and high risk factors were treated with chest radiotherapy， nutritional support by tube feeding help to maintain body weight， reduce adverse reactions， and reduce treatment interruption.

Key words

Esophageal cancer / Radiotherapy / Enteral nutrition

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CHENG Guo-wei， SUN Li， CHEN Ping， HE Xiang-ling， SU Dan， XI Heng-zhi， ZANG Ding-qi. Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients[J]. Electronic Journal of Metabolism and Nutrition of Cancer. 2019, 6(3): 332-336 https://doi.org/10.16689/j.cnki.cn11-9349/r.2019.03.012

References

1.杨丽萍，高劲，周燕，等. 营养干预对食管癌同步放化疗疗效研究. 中华放射肿瘤学杂志. 2018；(9):810-813.
2.徐桂琼，李民英，雷风，等. 经鼻肠管肠内营养支持在食管癌放疗患者中的应用. 中国基层医药.2017；24(2):228-231.
3.詹文明，陈芳洁，贾勇士，等. 营养风险筛查工具(NRS-2002)对不可手术的食管鳞癌患者同步放化疗疗效和不良反应的相关性分析. 中华放射肿瘤学杂志.2018；27(8):734-739.
4.王琳，陈梅，明智，等. 食管癌根治术后辅助放化疗不良反应与临床因素的关系. 实用癌症杂志.2017；32(9):1482-1485.
5.罗丽群，冯洁栈. 留置鼻胃管注食在食管癌同步放化疗中的应用及效果. 现代医药卫生.2015;31(10):1455-1457.
6.Arends J， Bodoky G， Bozzetti F， et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 2006;25(2):245-259.
7.李涛，吕家华，郞锦义等.恶性肿瘤放射治疗患者肠内营养专家共识. 肿瘤代谢与营养电子杂志. 2018；5(4):272-279.
8.Elia M，Van Bokhorst-de van der Schueren MA， Garvey J， et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol. 2006;28(1):5-23.
9.Koom WS， Ahn SD， Song SY， et al. Nutritional status of patients treated with radiotherapy as determined by subjective global assessment. Radiat Oncol J. 2012;30(3):132-139.
10.Miller KR， Bozeman MC. Nutrition therapy issues in esophageal cancer. Curr Gastroenterol Rep. 2012;14(4):356-366.
11.周鹏飞. 放射性食管炎治疗进展综述. 医学前沿. 2018;8(21):6-7.
12.Büntzel J， Kraus T， Büntzel H， et al. Nutritional parameters for patients with head and neck cancer. Anticancer Res. 2012;32(5):2119-2123.
13.Wu J， Huang C， Xiao H， et al. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition. 2013;29(11-12):1310-1314.
14.吕家华，李涛，朱广迎，等. 肠内营养对食管癌同步放化疗患者营养状况、不良反应和近期疗效影响—前瞻性、多中心、随机对照临床研究(NCT02399306). 中华放射肿瘤学杂志. 2018;27(1):44-48.
15.Prado CM， Baracos VE， McCargar LJ， et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007;13(11):3264-3268.
16.Odelli C， Burgess D， Bateman L， et al. Nutrition support improves patient outcomes， treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol(R Coll Radioi).2005;17(8):639-645.
17.丛明华，李淑娈，程国威，等. 营养支持小组对于食管癌同步放化疗患者作用的研究. 中国肿瘤临床.2014；41(18):1158-1162.
18.Jiang N， Zhao JZ， Chen XC， et al. Clinical determinants of weight loss in patients with esophageal carcinoma during radiotherapy: a prospective longitudinal view. Asian Pac J Cancer Prev. 2014;15(5):1943-1948.
19.Botella Carretero JI， Santacruz E， Vega-Pieiro B， et al. Gastrostomy vsnasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy. Nutr Hosp. 2017;34(3):512-516.
20.安玉玲，熊亮，刘剑戎，等. 鼻肠管肠内营养在重型颅脑损伤患者中的作用. 中国脑血管病杂志.2016；13(3):128-133.